Lower versus standard sucrose dose for treating hypoglycemia in patients with type 1 diabetes mellitus in therapy with predictive low glucose suspend (PLGS) augmented insulin pumps: A randomized crossover trial in Santiago, Chile
Publication date: Available online 23 March 2021Source: Diabetes & Metabolic Syndrome: Clinical Research & ReviewsAuthor(s): Bruno Grassi, María Teresa Onetto, Yazmín Zapata, Paulina Jofré, Guadalupe Echeverría
Source: Diabetes and Metabolic Syndrome: Clinical Research and Reviews - Category: Endocrinology Source Type: research
More News: Chile Health | Diabetes | Diabetes Mellitus | Diabetes Type 1 | Endocrinology | Insulin | Metabolic Syndrome